Rational Use of Medication in Pregnant Women

Introduction: the use of medication in pregnancy is a worldwide health challenge, since it can cause complications for both the pregnant woman and the fetus, and this risk is potentially increased in the first gestational trimester. Objectives: The objective of this article is to conduct a literature review on the rational use of medication in pregnant women. Materials and methods: The articles published from 2013 to 2019 in Portuguese - Brazil were used for the development of this literature review through an electronic search in the platforms: SCIELO - Scientific Electronic Library Online and Google Academic. Results and Discussion: 14 articles were analyzed, which showed a reflection on the effects of the use of drugs during pregnancy, where the perceptions of the authors were divergent, between the certainty that everything is harmful or everything is beneficial. Conclusion: Great variations were observed regarding the use of medication, in the same way, that the need for intervention promoting an increase in the rational use of medication is evident

The Indiscriminate use of Ritalin by Universities in the Health Area at the University of Gurupi – UNIRG

MPH methylphenidate, popularly known as Ritalin, was synthesized in 1954 in Switzerland and marketed in Brazil in 1998, belonging to the class of amphetamines. It acts in the CNS crossing the blood-brain barrier very easily. Used for cognitive improvement by college students. Its excessive consumption leads to dependence and possible side effects. The objective of this study was to analyze 91 university students who answered questionnaires on the theme. The collected data analyzed the incidence of Ritalin use among health academics at the University of Gurupi-UNIRG. After conducting the surveys, it was intended to understand the real reason that leads the student to the indiscriminate use of the drug and its possible consequences, to subsequently conduct guidance regarding the use without a prescription for academic purposes

Therapies for neonates with congenital malformations admitted to a neonatal unit

The aim of this study was to characterize the treatments applied to newborns with congenital malformation hospitalized in a neonatal unit and to identify whether there is an association among the treatments used and the type of malformation. A descriptive, prospective and quantitative study was developed in a public institution in Fortaleza, Ceará, Brazil. Data were collected using the medical records of 30 neonates with congenital malformations. The incidence of malformations was higher among females, regardless of the mother’s age, gestational age or weight at birth; malformations of the central nervous and musculoskeletal systems prevailed. The treatments used varied according to the clinical evolution of the neonate. The data collected did not present statistical significance when associated with the variable of congenital malformation and the treatments used (p>0.05). The treatments are not directly related to the type of malformation, but to the clinical condition of the neonate